Increased Risk Of Type 2 Diabetes And Insulin Resistance With The Severity Or Higher Body Surface Area (BSA) Of Psoriasis
Psoriasis is a common dermatological or inflammatory skin disease and a lifelong autoimmune disease. About two to four percent of the adults were affected by psoriasis. An earlier study shows an association between psoriasis and the heart attack (the medical name is myocardial infarction), cardiovascular diseases, stroke, mortality (death), type 2 diabetes (T2D) and chronic inflammation.
A study at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States shows the risk of type 2 diabetes (T2D) in the people with psoriasis and the risk of type 2 diabetes (T2D) increases with the severity of psoriasis. This is the first study exploring the effects on type 2 diabetes (T2D) with the severity of psoriasis. This study has found a biological connection between type 2 diabetes (T2D) and psoriasis. The study also found that psoriasis promotes insulin resistance.
A study on 8,124 people with psoriasis and 76,599 people without psoriasis, has collected the body surface area (BSA) of the psoriasis patients. The body surface area (BSA) shows the severity of psoriasis. They have done a follow-up study for four years.
The follow-up study shows a new type 2 diabetes development in 280 (3.44 percent) people in the psoriasis group and 1,867 (2.44 percent) people in without psoriasis group. Researchers accounted for risk factors to type 2 diabetes (T2D) such as the age of an individual, sex, obesity ( body mass index. BMI ). The study has found the following.
Researchers say that the healthcare professionals should provide a special attention for the prevention of type 2 diabetes (T2D) in the patients with psoriasis with the body surface area (BSA) more than ten, as they are at a higher risk to type 2 diabetes.
The lead author of the study was Joel M. Gelfand, a professor of dermatology and epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States. The study was published November 8, 2017, in the Journal of the American Academy of Dermatology. Title of the article was "Psoriasis and the Risk of Diabetes: A Prospective Population-Based Cohort Study."
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.